Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

The authors conducted a nested case-control study of serum inflammatory markers and risk of symptomatic benign prostatic hyperplasia (BPH), using data from the placebo arm of the Prostate Cancer Prevention Trial (1993–2003). Incident BPH (n = 676) was defined as treatment, report of 2 International...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Schenk, Jeannette M., Kristal, Alan R., Neuhouser, Marian L., Tangen, Catherine M., White, Emily, Lin, Daniel W., Kratz, Mario, Thompson, Ian M.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2010
Предметы:
Original Contributions
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842217/
https://ncbi.nlm.nih.gov/pubmed/20142396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwp406
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы